Aspire Biopharma Holdings (ASBP) Operating Margin (2025 - 2026)
Aspire Biopharma Holdings (ASBP) posted quarterly Operating Margin of 5805.98% for Q1 2026, up 86.62% quarter-over-quarter from 43403.52% in Q4 2025.
Aspire Biopharma Holdings (ASBP) Operating Margin (2025 - 2026) Analysis & Trends
Aspire Biopharma Holdings (ASBP) has reported Operating Margin for 2 consecutive years, with 5805.98% the latest figure, recorded in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.90 Bn | 131.05 Bn | 2.84 Bn | 37.40% |
| 2 | Regeneron Pharmaceuticals | 86.10 Bn | 78.11 Bn | 3.93 Bn | 30.15% |
| 3 | Argenx Se | 65.56 Bn | 60.37 Bn | 1.37 Bn | 32.54% |
| 4 | Moderna | 55.82 Bn | 50.68 Bn | 52.00 Mn | -562.07% |
| 5 | BeOne Medicines | 42.14 Bn | 37.04 Bn | 1.53 Bn | 19.06% |
| 6 | Alnylam Pharmaceuticals | 31.67 Bn | 28.36 Bn | 992.69 Mn | 17.93% |
| 7 | BioNTech SE | 27.74 Bn | 9.35 Bn | 668.28 Mn | -35.57% |
| 8 | Insmed | 27.53 Bn | 26.37 Bn | 358.27 Mn | -0.36% |
| 9 | Royalty Pharma | 27.38 Bn | 26.54 Bn | - | 19.75% |
| 10 | Aspire Biopharma Holdings | 8.29 Mn | -3.87 Mn | -30,086.00 | -4,244.14% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -4,244.14% |
| Mar 31, 2026 | -5,805.98% |
| Dec 31, 2025 | -43,403.52% |
| Sep 30, 2025 | -59,015.82% |